The Next Era: Deep Learning in Pharmaceutical Research.

Area of Science:

• Computational chemistry and cheminformatics
• Machine learning and artificial intelligence in drug discovery

Background:

• Machine learning algorithms are increasingly sophisticated and widely used across various industries.
• Pharmaceutical research is leveraging machine learning to analyze large datasets for drug discovery.
• Deep learning, a subset of machine learning, utilizes multi-layered artificial neural networks.

Purpose of the Study:

• To provide a balanced review of deep learning techniques in pharmaceutical research.
• To explore the application of deep learning across diverse pharmaceutical research endpoints.
• To highlight potential applications of deep learning beyond traditional cheminformatics.

Main Methods:

• Review of recent publications on deep learning in pharmaceutical research.
• Analysis of deep learning's predictive performance compared to traditional machine learning.
• Exploration of deep learning applications in areas like property prediction, ADME/Tox, and target identification.

Main Results:

• Deep learning methods demonstrate a potential advantage over previous machine learning approaches.
• Publications suggest a discernable edge in predictive performance for deep learning.
• Deep learning shows promise for various pharmaceutical research endpoints, including physicochemical properties, formulation, ADME/Tox, target prediction, and skin permeation.

Conclusions:

• Deep learning offers significant potential for advancing pharmaceutical research and drug discovery.
• Wider application of deep learning across various endpoints is encouraged.
• Prospective testing is crucial to validate the benefits and encourage investment in deep learning techniques.